Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated (Changed) | Updated to: 2026-01-21 | Was: 2026-01-05 |
| Drug Identification Number | 02278251 | 02278251 |
| Brand name | DUOTRAV PQ | DUOTRAV PQ |
| Common or Proper name | DUOTRAV BAK-FREE SOLN. 5ML | DUOTRAV BAK-FREE SOLN. 5ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC | NOVARTIS PHARMACEUTICALS CANADA INC |
| Ingredients | TRAVOPROST TIMOLOL | TRAVOPROST TIMOLOL |
| Strength(s) | 0.004% 0.5% | 0.004% 0.5% |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC | OPHTHALMIC OPHTHALMIC |
| Packaging size | 5 ML | 5 ML |
| Additional packaging sizes | ||
| ATC code | S01ED | S01ED |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2026-01-19 | 2026-01-19 |
| Actual start date | ||
| Estimated end date (Changed) | Updated to: 2026-03-04 | Was: 2026-02-12 |
| Actual end date | ||
| Shortage status (Changed) | Updated to: Actual shortage | Was: Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Product on allocation to minimize patient impact. | Product on allocation to minimize patient impact. |
| Health Canada comments |